GSK plc (GSK) has a current Price-to-Book (P/B) ratio of 9.20. Compared to its 3-year average P/B ratio of 5.00, the current P/B ratio is approximately 83.77% higher. Relative to its 5-year average P/B ratio of 5.01, the current P/B ratio is about 83.51% higher. GSK plc (GSK) has a Forward Free Cash Flow (FCF) yield of approximately 8.81%. Compared to its 3-year average FCF yield of 8.82%, the current FCF yield is approximately -0.16% lower. Relative to its 5-year average FCF yield of 9.61%, the current FCF yield is about -8.36% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for GSK competitors is 4.46, providing a benchmark for relative valuation. GSK plc Corp (GSK.N) exhibits a P/S ratio of 2.17, which is -51.28% above the industry average. Given its robust revenue growth of 10.24%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of GSK increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of GSK in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is GSK currently overvalued or undervalued?

What is GSK plc (GSK) fair value?

GSK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of GSK plc (GSK) is between 40.90 to 74.10 according to relative valuation method.

How does GSK's valuation metrics compare to the industry average?

The average P/S ratio for GSK's competitors is 4.46, providing a benchmark for relative valuation. GSK plc Corp (GSK) exhibits a P/S ratio of 2.17, which is -51.28% above the industry average. Given its robust revenue growth of 10.24%, this premium appears unsustainable.

What is the current P/B ratio for GSK plc (GSK) as of Mar 02 2026?

As of Mar 02 2026, GSK plc (GSK) has a P/B ratio of 9.20. This indicates that the market values GSK at 9.20 times its book value.

What is the current FCF Yield for GSK plc (GSK) as of Mar 02 2026?

As of Mar 02 2026, GSK plc (GSK) has a FCF Yield of 8.81%. This means that for every dollar of GSK plc's market capitalization, the company generates 8.81 cents in free cash flow.

What is the current Forward P/E ratio for GSK plc (GSK) as of Mar 02 2026?

As of Mar 02 2026, GSK plc (GSK) has a Forward P/E ratio of 11.04. This means the market is willing to pay $11.04 for every dollar of GSK plc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for GSK plc (GSK) as of Mar 02 2026?

As of Mar 02 2026, GSK plc (GSK) has a Forward P/S ratio of 2.17. This means the market is valuing GSK at $2.17 for every dollar of expected revenue over the next 12 months.

GSK Valuation